Cryptorchidism: An indicator of testicular dysgenesis?

Cell and Tissue Research

Volumn 322, Issue 1, 2005, Pages 167-172

  Kaleva, Marko ^a   Toppari, Jorma ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Cryptorchidism; Environment; Genetics; Human; Insl3; Testicular dysgenesis; Testis

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; G PROTEIN COUPLED RECEPTOR; GONADORELIN; GONADOTROPIN; HORMONE; INSULIN LIKE HORMONE 3; PLACEBO; UNCLASSIFIED DRUG;

CANCER RISK; CLINICAL TRIAL; CRYPTORCHISM; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FETUS DEVELOPMENT; GENE MUTATION; GENETIC POLYMORPHISM; HERITABILITY; HORMONAL THERAPY; HUMAN; HYPOPHYSIS GONAD SYSTEM; INCIDENCE; LIGAMENT; MALE FERTILITY; META ANALYSIS; NONHUMAN; ORCHIDOPEXY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SEASONAL VARIATION; SYSTEMATIC REVIEW; TESTIS CANCER; TESTIS DESCENT; TESTIS DISEASE; TESTIS DYSGENESIS;

ANDROGENS; CRYPTORCHIDISM; FEMALE; GONADOTROPINS; HUMANS; MALE; RISK FACTORS; TESTIS;

EID: 27944499887     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-005-1143-3     Document Type: Review

References (83)

1. Adham IM, Agoulnik AI (2004) Insulin-like 3 signalling in testicular descent. Int J Androl 27:257-265
2. Adham IM, Steding G, Thamm T, Bullesbach EE, Schwabe C, Paprotta I, Engel W (2002) The overexpression of the insl3 in female mice causes descent of the ovaries. Mol Endocrinol 16:244-252
3. Akre O, Lipworth L, Cnattingius S, Sparen P, Ekbom A (1999) Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 10:364-369
4. Andolz P, Bielsa MA, Andolz A (2001) Circannual variation in human semen parameters. Int J Androl 24:266-271
5. Baker LA, Docimo SG, Surer I, Peters C, Cisek L, Diamond DA, Caldamone A, Koyle M, Strand W, Moore R, Mevorach R, Brady J, Jordan G, Erhard M, Franco I (2001) A multi-institutional analysis of laparoscopic orchidopexy. BJU Int 87:484-489
6. Baker LA, Nef S, Nguyen MT, Stapleton R, Nordenskjold A, Pohl H, Parada LF (2002) The insulin-3 gene: lack of a genetic basis for human cryptorchidism. J Urol 167:2534-2537
7. Bartlett JE, Lee SM, Mishina Y, Behringer RR, Yang N, Wolf J, Temelcos C, Hutson JM (2002) Gubernacular development in Mullerian inhibiting substance receptor-deficient mice. BJU Int 89:113-118
8. Bergh A (1988) Treatment with human chorionic gonadotropin induces inflammation-like changes in the testicular microcirculation in adult unilaterally cryptorchid rats. Horm Res 30:207-209
9. Bergh A, Damber JE, Hjertkvist M (1996) Human chorionic gonadotrophin-induced testicular inflammation may be related to increased sensitivity to interleukin-1. Int J Androl 19:229-236
10. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR (1993) Prevalence and natural history of cryptorchidism. Pediatrics 92:44-49
11. Bertini V, Bertelloni S, Valetto A, Lala R, Foresta C, Simi P (2004) Homeobox HOXA10 gene analysis in cryptorchidism. J Pediatr Endocrinol Metab 17:41-45
12. Boehmer AL, Brinkmann O, Bruggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwe CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL (2001) Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86:4151-4160
13. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI (2003) GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol 17:2639-2646
14. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J (2004) Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264-1269
15. Bollerslev J, Rohl H, Krag Sorensen E, Bennet P (1986) Gonadotropin and androgen levels in patients operated upon for cryptorchidism. Dan Med Bull 33:336-338
16. Cain MP, Kramer SA, Tindall DJ, Husmann DA (1994) Epidermal growth factor reverses antiandrogen induced cryptorchidism and epididymal development. J Urol 152:770-773, discussion 774-775
17. Canto P, Escudero I, Soderlund D, Nishimura E, Carranza-Lira S, Gutierrez J, Nava A, Mendez JP (2003) A novel mutation of the insulin-like 3 gene in patients with cryptorchidism. J Hum Genet 48:86-90
18. Chang B, Palmer LS, Franco I (2001) Laparoscopic orchidopexy: a review of a large clinical series. BJU Int 87:490-493
19. Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth ME (1984) Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet 2:330-332
20. Coupland CA, Chilvers CE, Davey G, Pike MC, Oliver RT, Forman D (1999) Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom testicular cancer study group. Br J Cancer 80:1859-1863
21. Czeizel A, Erodi E, Toth J (1981) An epidemic logical study on undescended testis. J Urol 126:524-527
22. Docimo SG (1995) The results of surgical therapy for cryptorchidism: a literature review and analysis. J Urol 154:1148-1152
23. Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikstrom S (1997) Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 100:2341-2346
24. Elert A, Jahn K, Heidenreich A, Hofmann R (2003) The familial undescended testis. Klin Padiatr 215:40-45
25. Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO (2000) Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141:846-849
26. Ferlin A, Simonato M, Bartoloni L, Rizzo G, Bettella A, Dottorini T, Dallapiccola B, Foresta C (2003) The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. J Clin Endocrinol Metab 88:4273-4279
27. Fisher JS, Macpherson S, Marchetti N, Sharpe RM (2003) Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod 18:1383-1394
28. Gendrel D, Job JC, Roger M (1978) Reduced post-natal rise of testosterone in plasma of cryptorchid infants. Acta Endocrinol (Copenh) 89:372-378
29. Gendrel D, Roger M, Job JC (1980) Plasma gonadotropin and testosterone values in infants with cryptorchidism. J Pediatr 97:217-220
30. Gill WB, Schumacher GF, Bibbo M, Straus FH II, Schoenberg HW (1979) Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 122:36-39
31. Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE (1987) Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol 138:1214-1216
32. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, Bishop CE, McElreavey K, Agoulnik AI (2002) Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 11:2309-2318
33. Grocock CA, Charlton HM, Pike MC (1988) Role of the fetal pituitary in cryptorchidism induced by exogenous maternal oestrogen during pregnancy in mice. J Reprod Fertil 83:295-300
34. Group JRHCS (1986) Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe hospital cryptorchidism study group. Br Med J (Clin Res Ed) 293:1401-1404
35. Group JRHCS (1992) Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe hospital cryptorchidism study group. Arch Dis Child 67:892-899
36. Haavisto T, Nurmela K, Pohjanvirta R, Huuskonen H, El-Gehani F, Paranko J (2001) Prenatal testosterone and luteinizing hormone levels in male rats exposed during pregnancy to 2,3,7,8-tetrachlorodibenzo-p-dioxin and diethylstilbestrol. Mol Cell Endocrinol 178:169-179
37. Haavisto A-M, Main KM, Kaleva M, Schmidt IM, Chellakooty M, Virtanen HE, Boisen KA, Damgaard IN, Kai CM, Skakkebaek NE, Toppari J (2005) Hormonal changes in 3-month-old cryptorchid boys. J Clin Endocr Metab (pending after revision)
38. Hadziselimovic F, Geneto R, Emmons LR (2000) Elevated placental estradiol: a possible etiological factor of human cryptorchidism. J Urol 164:1694-1695
39. Heiskanen P, Billig H, Toppari J, Kaleva M, Arsalo A, Rapola J, Dunkel L (1996) Apoptotic cell death in the normal and cryptorchid human testis: the effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 40:351-356
40. Henna MR, Del Nero RG, Sampaio CZ, Atallah AN, Schettini ST, Castro AA, Soares BG (2004) Hormonal cryptorchidism therapy: systematic review with metanalysis of randomized clinical trials. Pediatr Surg Int 20:357-359
41. Hjertkvist M, Damber JE, Bergh A (1989) Cryptorchidism: a registry based study in Sweden on some factors of possible aetiological importance. J Epidemiol Community Health 43:324-329
42. Hjertkvist M, Lackgren G, Ploen L, Bergh A (1993) Does HCG treatment induce inflammation-like changes in undescended testes in boys? J Pediatr Surg 28:254-258
43. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ (2002) Activation of orphan receptors by the hormone relaxin. Science 295:671-674
44. Job JC, Gendrel D, Safar A, Roger M, Chaussain JL (1977) Pituitary LH and FSH and testosterone secretion in infants with undescended testes. Acta Endocrinol (Copenh) 85:644-649
45. Job JC, Toublanc JE, Chaussain JL, Gendrel D, Gamier P, Roger M (1988) Endocrine and immunological findings in cryptorchid infants. Horm Res 30:167-172
46. Jones ME, Swerdlow AJ, Griffith M, Goldacre MJ (1998) Prenatal risk factors for cryptorchidism: a record linkage study. Paediatr Perinat Epidemiol 12:383-396
47. Jorgensen N, Andersen AG, Eustache F, Irvine DS, Suominen J, Petersen JH, Andersen AN, Auger J, Cawood EH, Horte A, Jensen TK, Jouannet P, Keiding N, Vierula M, Toppari J, Skakkebaek NE (2001) Regional differences in semen quality in Europe. Hum Reprod 16:1012-1019
48. Kaleva M, Arsalo A, Louhimo I, Rapola J, Perheentupa J, Henriksen K, Toppari J (1996) Treatment with human chorionic gonadotrophin for cryptorchidism: clinical and histological effects. Int J Androl 19:293-298
49. Kaleva M, Virtanen HE, Haavisto, A-M, Main KM, Reunanen M, Skakkebaek NE, Toppari J (2005) Circannual rhythm in the incidence of cryptorchidism in Finland. Int J Androl 28:53-57
50. Kiely EA, Chapman RS, Bajoria SK, Hollyer JS, Hurley R (1995) Maternal serum human chorionic gonadotrophin during early pregnancy resulting in boys with hypospadias or cryptorchidism. Br J Urol 76:389-392
51. Kolon TF, Wiener JS, Lewitton M, Roth DR, Gonzales ET Jr, Lamb DJ (1999) Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 161:275-280
52. Koskimies P, Virtanen H, Lindstrom M, Kaleva M, Poutanen M, Huhtaniemi I, Toppari J (2000) A common polymorphism in the human relaxin-like factor (RLF) gene: no relationship with cryptorchidism. Pediatr Res 47:538-541
53. Koskimies P, Suvanto M, Nokkala E, Huhtaniemi IT, McLuskey A, Themmen AP, Poutanen M (2003) Female mice carrying a ubiquitin promoter-Insl3 transgene have descended ovaries and inguinal hernias but normal fertility. Mol Cell Endocrinol 206:159-166
54. Krausz C, Quintana-Murci L, Fellous M, Siffroi JP, McElreavey K (2000) Absence of mutations involving the INSL3 gene in human idiopathic cryptorchidism. Mol Hum Reprod 6:298-302
55. Kubota Y, Temelcos C, Bathgate RA, Smith KJ, Scott D, Zhao C, Hutson JM (2002) The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 8:900-905
56. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, Bathgate RA, Hsueh AJ (2002) INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277:31283-31286
57. Lee PA, Coughlin MT (2001) Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data. Horm Res 55:28-32
58. Lim HN, Raipert-de Meyts E, Skakkebaek NE, Hawkins JR, Hughes IA (2001) Genetic analysis of the INSL3 gene in patients with maldescent of the testis. Eur J Endocrinol 144:129-137
59. Marin P, Ferlin A, Moro E, Garolla A, Foresta C (2001) Different insulin-like 3 (INSL3) gene mutations not associated with human cryptorchidism. J Endocrinol Invest 24:RC13-RC15
60. Martikainen H, Tapanainen J, Vakkuri O, Leppaluoto J, Huhtaniemi I (1985) Circannual concentrations of melatonin, gonadotrophins, prolactin and gonadal steroids in males in a geographical area with a large annual variation in daylight. Acta Endocrinol (Copenh) 109:446-450
61. McIntyre BS, Barlow NJ, Foster PM (2001) Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 62:236-249
62. McKinnell C, Atanassova N, Williams K, Fisher JS, Walker M, Turner KJ, Saunders TK, Sharpe RM (2001) Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol. J Androl 22:323-338
63. McLachlan JA (1979) Transplacental effects of diethylstilbestrol in mice. Natl Cancer Inst Monogr 67-72
64. Meriggiola MC, Noonan EA, Paulsen CA, Bremner WJ (1996) Annual patterns of luteinizing hormone, follicle stimulating hormone, testosterone and inhibin in normal men. Hum Reprod 11:248-252
65. Moller H, Prener A, Skakkebaek NE (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 7:264-274
66. Morrish DW, Bhardwaj D, Dabbagh LK, Marusyk H, Siy O (1987) Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab 65:1282-1290
67. Nef S, Parada LF (1999) Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295-299
68. Nef S, Shipman T, Parada LF (2000) A molecular basis for estrogen-induced cryptorchidism. Dev Biol 224:354-361
69. Norgil Damgaard I, Main KM, Toppari J, Skakkebaek NE (2002) Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction. Best Pract Res Clin Endocrinol Metab 16:289-309
70. Overbeek PA, Gorlov IP, Sutherland RW, Houston JB, Harrison WR, Boettger-Tong HL, Bishop CE, Agoulnik AI (2001) A transgenic insertion causing cryptorchidism in mice. Genesis 30:26-35
71. Prener A, Engholm G, Jensen OM (1996) Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 7:14-19
72. Pyorala S, Huttunen NP, Uhari M (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 80:2795-2799
73. Raivio T, Toppari J, Kaleva M, Virtanen H, Haavisto AM, Dunkel L, Jänne OA (2003) Serum androgen bioactivity in cryptorchid and noncryptorchid boys during postnatal reproductive hormone surge. J Clin Endocrinol Metab 88:2597-2599
74. Rijli FM, Matyas R, Pellegrini M, Dierich A, Gruss P, Dolle P, Chambon P (1995) Cryptorchidism and homeotic transformations of spinal nerves and vertebrae in Hoxa-10 mutant mice. Proc Natl Acad Sci U S A 92:8185-8189
75. Roh J, Virtanen H, Kumagai J, Satoko S, Kaleva M, Toppari J, Hsueh AJ (2003) Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism. Reproductive BioMedicine Online 7:400-406
76. Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972-978
77. Swerdlow AJ, Wood KH, Smith PG (1983) A case-control study of the aetiology of cryptorchidism. J Epidemiol Community Health 37:238-244
78. Takahashi I, Takahashi T, Komatsu M, Matsuda J, Takada G (2001) Ala/Thr60 variant of the Leydig insulin-like hormone is not associated with cryptorchidism in the Japanese population. Pediatr Int 43:256-258
79. Tjoa WS, Smolensky MH, Hsi BP, Steinberger E, Smith KD (1982) Circannual rhythm in human sperm count revealed by serially independent sampling. Fertil Steril 38:454-459
80. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF (2000) Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 85:4013-4018
81. Toppari J, Kaleva M (1999) Maldescendus testis. Horm Res 51:261-269
82. Weidner IS, Moller H, Jensen TK, Skakkebaek NE (1999) Risk factors for cryptorchidism and hypospadias. J Urol 161:1606-1609
83. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM (1999) Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13:681-691